Acute Hepatic Porphyria (AHP)

International Congress of Porphyrins and Porphyrias (ICPP) 2024

Congress Details

September 21-25, 2024

Pamplona, Spain

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Congress Materials

ICPP-2024-ENVISION-oral-presentation-slides-74

Presentation Type

Presentation

Location

Pamplona, Spain

Title

Long-term clinical outcomes of patients with acute hepatic porphyria who were not attack-free after 6-months of givosiran treatment: a subgroup analysis of the phase 3 ENVISION study